Serum Procalcitonin Study in the Management of Ventilated Patients
| Status: | Completed |
|---|---|
| Conditions: | Pneumonia |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/2/2016 |
| Start Date: | September 2008 |
| End Date: | August 2010 |
| Contact: | Tara M Powell, ASN, RN |
| Email: | powelltm@health.missouri.edu |
| Phone: | 573-882-4976 |
Clinical Utility of Serum Procalcitonin in the Management of Ventilator-Associated Pneumonia
The purpose of this study is to test a new method for diagnosing and monitoring
Ventilator-Associated Pneumonia, which is a major killer among ICU patients. The method
requires analysis of a small amount of the patient's blood for concentration of a hormone
called Procalcitonin.
Ventilator-Associated Pneumonia, which is a major killer among ICU patients. The method
requires analysis of a small amount of the patient's blood for concentration of a hormone
called Procalcitonin.
Ventilator-associated pneumonia is a leading cause of mortality in critically ill patients.
The purpose of this study is to evaluate the relationship between the
onset/progress/resolution of pneumonia and the levels of Procalcitonin, a prohormone whose
concentrations fluctuate in response to bacterial infection.
The purpose of this study is to evaluate the relationship between the
onset/progress/resolution of pneumonia and the levels of Procalcitonin, a prohormone whose
concentrations fluctuate in response to bacterial infection.
Inclusion Criteria:
- Are willing to give or who's proxy is willing to consent to be a study subject
- Are at least 18 years of age;
- Who are mechanically ventilated surgical intensive care unit patients.
Exclusion Criteria:
- Participation in any investigational device or drug trial within 30 days prior to
enrollment.
We found this trial at
1
site
University of Missouri T he University of Missouri was founded in 1839 in Columbia, Mo.,...
Click here to add this to my saved trials
